Blood group definition describes the classification of human blood based on inherited antigens on the surface of red blood cells. These antigens determine compatibility for safe blood transfusion and influence disease risk. Understanding the major blood group systems and their practical implications helps healthcare providers personalize treatment and reduce adverse reactions.
Modern transfusion medicine relies on precise serologic and genetic testing to identify each person’s phenotype and genotype. This structured overview introduces the key systems, clinical relevance, and real-world considerations in clear, actionable terms.
| Blood Group System | Key Antigens | Clinical Importance | Common Antibodies |
|---|---|---|---|
| ABO | A, B, H | Major transfusion compatibility; determines universal donor/recipient concepts | Anti-A, Anti-B, Anti-A+B |
| Rh | D, C/c, E/e | RhD status critical in pregnancy and transfusion; Rh immunoglobulin prophylaxis | Anti-D, Anti-c, Anti-E |
| Kell | K, k | Kell antibodies often severe; historical significance in HDN | Anti-K |
| Duffy | Fya, Fyb | Fya and Fyb antibodies usually mild; population distribution relevant for donor sourcing | Anti-Fya, Anti-Fyb |
| Kidd | Jka, Jkb | Anti-Jka and Anti-Jkb potentially severe; delayed hemolytic reactions possible | Anti-Jka, Anti-Jkb |
ABO Blood Group System Fundamentals
The ABO system is the primary classification used in everyday transfusion and organ allocation. It is defined by carbohydrate antigens encoded by A, B, and O alleles on chromosome 9.
Blood Types and Antigen Expression
Type A expresses A antigen, type B expresses B antigen, type AB expresses both, and type O expresses neither. Corresponding naturally occurring antibodies develop without prior exposure, shaping transfusion compatibility rules.
Rh and Other High-Impact Systems
The Rh system, especially the D antigen, dominates prenatal and perinatal care. RhD-negative individuals can develop anti-D after exposure, making prophylaxis essential in pregnancy and after delivery or procedures.
Minor Antigen Groups in Detail
Kell, Duffy, Kidd, and Lutheran systems carry clinically significant antigens. Antibodies against these groups can cause delayed hemolytic transfusion reactions and hemolytic disease of the fetus and newborn when passive immunity wanes.
Antibody Formation and Clinical Impact
Exposure to foreign red cell antigens through pregnancy or transfusion stimulates active immunization. These immune complexes can persist for years and complicate future product choices.
Transfusion and Obstetric Considerations
Incompatible units trigger acute or delayed hemolysis, while alloimmunization in pregnancy raises risks for HDFN. Early antibody screening and antigen-typed blood products reduce these risks significantly.
Genotyping and Extended Phenotyping
Molecular methods identify variant alleles responsible for partial or weak antigen expression. These tests resolve serologic discrepancies and guide rare phenotype matching when standard serology is insufficient.
Applications in Pregnancy and Transplant
Genotyping predicts fetal antigen status non-invasively and supports haplotype-based donor selection in hematopoietic stem cell transplantation, improving outcomes and reducing relapse risk.
Key Takeaways and Practical Recommendations
- Confirm ABO and RhD status early in pregnancy and before any transfusion.
- Report prior transfusion reactions or pregnancies with HDFN to your care team immediately.
- Request antibody screening when unusual delays or reactions occur in prior care.
- Consider genetic counseling if you have rare phenotypes or complex family planning questions.
FAQ
Reader questions
How can I find out my blood group and Rh status?
Request ABO and RhD testing through your healthcare provider or a certified laboratory; results are typically available from a simple blood draw within one to two days.
Can two parents with type O blood have a child with type A or B?
No, because type O parents carry only O alleles; genetically they can only pass O alleles, so all children will be type O under standard inheritance rules.
What should I do if I had a transfusion reaction in the past and need new blood?
Inform your clinician and request antibody screening and extended red cell phenotyping to identify the responsible antibody and select antigen-negative units.
Is it necessary to repeat antibody screening during every pregnancy?
Yes, repeat screening at the first prenatal visit and around 28 weeks is standard to detect new alloimmunization and time RhIg administration appropriately.